The Asia Pacific region is emerging as a hotbed for the healthcare industry. The pharma, medical and biotech (PMB) sector saw 396 deals announced in the first half of 2023. Trends suggest a strong potential for growth in the region especially in emerging markets with increasingly affluent populations such as Southeast Asia and India.

Will the growing demand for personalized medicine and innovative treatments drive smaller-sized strategic M&A deals? Will deals focus more and more on companies that own cutting-edge technologies and intellectual property rights?

Learn more about dealmaking in healthcare across APAC and the countries that stand to gain as cross-border dealmaking is expected to increase in the coming months. Download the PMB chapter of the Deal Drivers: APAC HY 2023 report today.